Voriconazole metabolism is influenced by severe inflammation: a prospective study

被引:129
作者
Veringa, Anette [1 ]
ter Avest, Mendy [1 ]
Span, Lambert F. R. [2 ]
van den Heuvel, Edwin R. [3 ]
Touw, Daan J. [1 ]
Zijlstra, Jan G. [4 ]
Kosterink, Jos G. W. [1 ,5 ]
van der Werf, Tjip S. [6 ,7 ]
Alffenaar, Jan-Willem C. [1 ]
机构
[1] Univ Groningen, Univ Med Ctr Groningen, Dept Clin Pharm & Pharmacol, Groningen, Netherlands
[2] Univ Groningen, Univ Med Ctr Groningen, Dept Hematol, Groningen, Netherlands
[3] Eindhoven Univ Technol, Dept Math & Comp Sci, Eindhoven, Netherlands
[4] Univ Groningen, Univ Med Ctr Groningen, Dept Crit Care, Groningen, Netherlands
[5] Univ Groningen, Sect Pharmacotherapy & Pharmaceut Care, Dept Pharm, Groningen, Netherlands
[6] Univ Groningen, Univ Med Ctr Groningen, Dept Internal Med, Groningen, Netherlands
[7] Univ Groningen, Univ Med Ctr Groningen, Dept Pulm Dis & TB, Groningen, Netherlands
关键词
INVASIVE FUNGAL-INFECTIONS; DRUG-METABOLISM; PHARMACOKINETICS; SAFETY; EFFICACY; ENZYMES; TRANSPORTERS; GENOTYPE; OUTCOMES; DISEASE;
D O I
10.1093/jac/dkw349
中图分类号
R51 [传染病];
学科分类号
100401 ;
摘要
Background: During an infection or inflammation, several drug-metabolizing enzymes in the liver are downregulated, including cytochrome P450 iso-enzymes. Since voriconazole is extensively metabolized by cytochrome P450 iso-enzymes, the metabolism of voriconazole can be influenced during inflammation via reduced clearance of the drug, resulting in higher voriconazole trough concentrations. Objective: To investigate prospectively the influence of inflammation on voriconazole metabolism and voriconazole trough concentrations. Methods: A prospective observational study was performed at the University Medical Center Groningen. Patients were eligible for inclusion if they were >= 18 years old and treated with voriconazole. Voriconazole and voriconazole-N-oxide concentrations were determined in discarded blood samples. To determine the degree of inflammation, C-reactive protein (CRP) concentrations were used. Subsequently, a longitudinal data analysis was performed to assess the effect of inflammation on the metabolic ratio and voriconazole trough concentration. Results: Thirty-four patients were included. In total 489 voriconazole trough concentrations were included in the longitudinal data analysis. This analysis showed that inflammation, reflected by CRP concentrations, significantly influenced the metabolic ratio, voriconazole trough concentration and voriconazole-N-oxide concentration (all P < 0.001), when corrected for other factors that could influence voriconazole metabolism. The metabolic ratio was decreased by 0.99229(N) and the voriconazole-N-oxide concentration by 0.99775(N), while the voriconazole trough concentration was increased by 1.005321(N), where N is the difference in CRP units (in mg/L). Conclusions: This study shows that voriconazole metabolism is decreased during inflammation, resulting in higher voriconazole trough concentrations. Therefore, frequent monitoring of voriconazole serum concentrations is recommended during and following severe inflammation.
引用
收藏
页码:261 / 267
页数:7
相关论文
共 40 条
[1]   Regulation of drug-metabolizing enzymes and transporters in inflammation [J].
Aitken, AE ;
Richardson, TA ;
Morgan, ET .
ANNUAL REVIEW OF PHARMACOLOGY AND TOXICOLOGY, 2006, 46 :123-149
[2]   Gene-specific effects of inflammatory Cytokines on cytochrome P4502C, 2B6 and 3A4 mRNA levels in human Hepatocytes [J].
Aitken, Alison E. ;
Morgan, Edward T. .
DRUG METABOLISM AND DISPOSITION, 2007, 35 (09) :1687-1693
[3]   Method for therapeutic drug monitoring of azole antifungal drugs in human serum using LC/MS/MS [J].
Alffenaar, J. W. C. ;
Wessels, A. M. A. ;
van Hateren, K. ;
Greijdanus, B. ;
Kosterink, J. G. W. ;
Uges, D. R. A. .
JOURNAL OF CHROMATOGRAPHY B-ANALYTICAL TECHNOLOGIES IN THE BIOMEDICAL AND LIFE SCIENCES, 2010, 878 (01) :39-44
[4]   Pharmacokinetics and safety of 14 days intravenous voriconazole in allogeneic haematopoietic stem cell transplant recipients [J].
Bruggemann, Roger J. M. ;
Blijlevens, N. M. A. ;
Burger, David M. ;
Franke, Barbara ;
Troke, Peter F. ;
Donnelly, J. Peter .
JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY, 2010, 65 (01) :107-113
[5]   Clinical Relevance of the Pharmacokinetic Interactions of Azole Antifungal Drugs with Other Coadministered Agents [J].
Bruggemann, Roger J. M. ;
Alffenaar, Jan-Willem C. ;
Blijlevens, Nicole M. A. ;
Billaud, Eliane M. ;
Kosterink, Jos G. W. ;
Verweij, Paul E. ;
Burger, David M. .
CLINICAL INFECTIOUS DISEASES, 2009, 48 (10) :1441-1458
[6]   Multicenter Study of Voriconazole Pharmacokinetics and Therapeutic Drug Monitoring [J].
Dolton, Michael J. ;
Ray, John E. ;
Chen, Sharon C. -A. ;
Ng, Kingsley ;
Pont, Lisa G. ;
McLachlan, Andrew J. .
ANTIMICROBIAL AGENTS AND CHEMOTHERAPY, 2012, 56 (09) :4793-4799
[7]   Therapeutic Drug Monitoring of Voriconazole in the Management of Invasive Fungal Infections: A Critical Review [J].
Elewa, Hazem ;
El-Mekaty, Eman ;
El-Bardissy, Ahmed ;
Ensom, Mary H. H. ;
Wilby, Kyle John .
CLINICAL PHARMACOKINETICS, 2015, 54 (12) :1223-1235
[8]   Mechanisms of disease: Acute-phase proteins and other systemic responses to inflammation [J].
Gabay, C ;
Kushner, I .
NEW ENGLAND JOURNAL OF MEDICINE, 1999, 340 (06) :448-454
[9]   An update on C-reactive protein for intensivists [J].
Ho, K. M. ;
Lipman, J. .
ANAESTHESIA AND INTENSIVE CARE, 2009, 37 (02) :234-241
[10]   Red blood cell products: consideration of the discrepant temperature ranges permitted for storage versus transport [J].
Lee, Sally Campbell ;
Shaz, Beth ;
Arena, Roberto ;
Sloan, Steven ;
Fung, Mark ;
Ramsey, Glenn .
TRANSFUSION, 2012, 52 (01) :195-200